Empacoza Plus Film Coated Tablets

INDICATIONS AND USAGE :
• Empacoza plus, fixed dose combination of empagliflozin and linagliptin, is indicated in
adults aged 18 years and older with type 2 diabetes mellitus:
• To improve glycaemic control when metformin and/or sulphonylurea (SU) and one of
the monocomponents of Empacoza plus do not provide adequate glycaemic control.
• When already being treated with the free combination of empagliflozin and linagliptin